StockData
KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30

KAZIA THERAPEUTICS LTD

Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 7, 2025
$7.85+0.60 (+8.28%)

Close on Oct 19, 2026

KAZIA THERAPEUTICS LTD revenue by segment

No segment breakdown reported

Kazia Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.